Fifth Third Bancorp Heron Therapeutics, Inc. Transaction History

Fifth Third Bancorp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$4.63 - $9.94 $13,890 - $29,820	-3,000 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$13.27 - $18.48 $39,810 - $55,440	3,000 New	3,000 $47,000
Q3 2020 Nov 09, 2020	SELL	$13.67 - $17.77 $27,340 - $35,540	-2,000 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$10.89 - $21.47 $1,001 - $1,975	-92 Reduced 4.4%	2,000 $29,000
Q3 2019 Nov 14, 2019	BUY	$16.36 - $21.39 $1,505 - $1,967	92 Added 4.6%	2,092 $39,000
Q2 2019 Aug 07, 2019	BUY	$16.93 - $26.22 $25,395 - $39,330	1,500 Added 300.0%	2,000 $37,000
Q2 2017 Aug 11, 2017	BUY	N/A	500	500 $7,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.